Literature DB >> 19854208

Methods for genome-wide analysis of DNA methylation in intestinal tumors.

Maria A Hahn1, Gerd P Pfeifer.   

Abstract

Recent studies show that colorectal cancer is strongly associated with aberrant DNA methylation, which has been linked to the origin and progression of the disease. This fact indicates a need for deep analysis of DNA methylation alterations during colorectal carcinogenesis. The knowledge obtained from such studies will elucidate the mechanisms of epigenetic changes and, through the identification and characterization of DNA methylation markers and disease-specific methylation patterns, will help improve the diagnosis and treatment options for patients. The introduction of new methods for genome-wide analysis of DNA methylation has been an important step towards achieving these goals. In this review, we discuss the role of DNA methylation in intestinal carcinogenesis as well as the different methodological approaches that are currently being used for methylation analysis on a genome-wide scale. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854208      PMCID: PMC2891386          DOI: 10.1016/j.mrfmmm.2009.10.005

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  100 in total

1.  Dependence of McrBC cleavage on distance between recognition elements.

Authors:  F J Stewart; E A Raleigh
Journal:  Biol Chem       Date:  1998 Apr-May       Impact factor: 3.915

2.  Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred.

Authors:  Y Akiyama; H Sato; T Yamada; H Nagasaki; A Tsuchiya; R Abe; Y Yuasa
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

3.  DNA hypomethylation leads to elevated mutation rates.

Authors:  R Z Chen; U Pettersson; C Beard; L Jackson-Grusby; R Jaenisch
Journal:  Nature       Date:  1998-09-03       Impact factor: 49.962

4.  Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.

Authors:  M Toyota; C Ho; N Ahuja; K W Jair; Q Li; M Ohe-Toyota; S B Baylin; J P Issa
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

5.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

6.  Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis.

Authors:  Krisanee Chalitchagorn; Shanop Shuangshoti; Nusara Hourpai; Narisorn Kongruttanachok; Pisit Tangkijvanich; Duangporn Thong-ngam; Narin Voravud; Virote Sriuranpong; Apiwat Mutirangura
Journal:  Oncogene       Date:  2004-11-18       Impact factor: 9.867

7.  The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53.

Authors:  K D Robertson; P A Jones
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

8.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.

Authors:  J G Herman; A Umar; K Polyak; J R Graff; N Ahuja; J P Issa; S Markowitz; J K Willson; S R Hamilton; K W Kinzler; M F Kane; R D Kolodner; B Vogelstein; T A Kunkel; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.

Authors:  J M Cunningham; E R Christensen; D J Tester; C Y Kim; P C Roche; L J Burgart; S N Thibodeau
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

10.  Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.

Authors:  M L Veigl; L Kasturi; J Olechnowicz; A H Ma; J D Lutterbaugh; S Periyasamy; G M Li; J Drummond; P L Modrich; W D Sedwick; S D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  5 in total

1.  Widespread 5-methylcytosine in the genomes of avian Coccidia and other apicomplexan parasites detected by an ELISA-based method.

Authors:  Zhenxing Gong; Hao Yin; Xueting Ma; Baohong Liu; Zhenglan Han; Lingqiao Gou; Jianping Cai
Journal:  Parasitol Res       Date:  2017-03-30       Impact factor: 2.289

2.  Biomarkers in Barrett's Esophagus.

Authors:  Rhonda F Souza
Journal:  Tech Gastrointest Endosc       Date:  2010-04

3.  Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine.

Authors:  Seung-Gi Jin; Swati Kadam; Gerd P Pfeifer
Journal:  Nucleic Acids Res       Date:  2010-04-05       Impact factor: 16.971

4.  Genomic mapping of 5-hydroxymethylcytosine in the human brain.

Authors:  Seung-Gi Jin; Xiwei Wu; Arthur X Li; Gerd P Pfeifer
Journal:  Nucleic Acids Res       Date:  2011-03-04       Impact factor: 16.971

5.  LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.

Authors:  Yun-Ting Lou; Chao-Wen Chen; Yun-Ching Fan; Wei-Chiao Chang; Chien-Yu Lu; I-Chen Wu; Wen-Hung Hsu; Ching-Wen Huang; Jaw-Yuan Wang
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.